av/puretech-health--big.svg

NASDAQ:PRTC

PureTech Health plc

  • Stock

1.65

USD last updated 03/08 01:30:35

Last Close

1.65

01/05 20:00

Market Cap

555.22M

Beta: 0.82

Volume Today

1K

Avg: 765

PE Ratio

−18.26

PFCF: −3.55

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholine receptors to treat schizophren...Show More

    Earnings

    Earnings per Share (Estimate*)

    -55102017-03-312019-03-312020-12-312022-12-312024-06-06

    Revenue (Estimate*)

    2M4M6M8M10M12M2017-03-312019-03-312020-12-312022-12-312024-06-06

    *Estimate based on analyst consensus